About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Ophthalmic Drugs Market Size to Grow at a CAGR of 7.4% by 2030
Ophthalmic Drugs Market

Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Others), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis, Others), By Route of Administration (Topical, Local Ocular, Systemic), By Dosage Form (Gels, Eye Solutions and Suspensions, Capsules and Tablets, Eye drops, Ointments), By Product Type (Prescription, OTC) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH3493DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Ophthalmic Drugs Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    7. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-Allergy
          1. By Value
        3. Anti-VEGF agents
          1. By Value
        4. Anti-inflammatory
          1. By Value
        5. Anti-glaucoma
          1. By Value
        6. Others
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Dry Eye
          1. By Value
        3. Allergies
          1. By Value
        4. Glaucoma
          1. By Value
        5. Infection
          1. By Value
        6. Retinal Disorders
          1. By Value
        7. Uveitis
          1. By Value
        8. Others
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Topical
          1. By Value
        3. Local Ocular
          1. By Value
        4. Systemic
          1. By Value
      4. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Gels
          1. By Value
        3. Eye Solutions and Suspensions
          1. By Value
        4. Capsules and Tablets
          1. By Value
        5. Eye drops
          1. By Value
        6. Ointments
          1. By Value
      5. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
    8. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    7. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-Allergy
          1. By Value
        3. Anti-VEGF agents
          1. By Value
        4. Anti-inflammatory
          1. By Value
        5. Anti-glaucoma
          1. By Value
        6. Others
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Dry Eye
          1. By Value
        3. Allergies
          1. By Value
        4. Glaucoma
          1. By Value
        5. Infection
          1. By Value
        6. Retinal Disorders
          1. By Value
        7. Uveitis
          1. By Value
        8. Others
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Topical
          1. By Value
        3. Local Ocular
          1. By Value
        4. Systemic
          1. By Value
      4. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Gels
          1. By Value
        3. Eye Solutions and Suspensions
          1. By Value
        4. Capsules and Tablets
          1. By Value
        5. Eye drops
          1. By Value
        6. Ointments
          1. By Value
      5. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    7. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-Allergy
          1. By Value
        3. Anti-VEGF agents
          1. By Value
        4. Anti-inflammatory
          1. By Value
        5. Anti-glaucoma
          1. By Value
        6. Others
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Dry Eye
          1. By Value
        3. Allergies
          1. By Value
        4. Glaucoma
          1. By Value
        5. Infection
          1. By Value
        6. Retinal Disorders
          1. By Value
        7. Uveitis
          1. By Value
        8. Others
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Topical
          1. By Value
        3. Local Ocular
          1. By Value
        4. Systemic
          1. By Value
      4. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Gels
          1. By Value
        3. Eye Solutions and Suspensions
          1. By Value
        4. Capsules and Tablets
          1. By Value
        5. Eye drops
          1. By Value
        6. Ointments
          1. By Value
      5. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    7. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-Allergy
          1. By Value
        3. Anti-VEGF agents
          1. By Value
        4. Anti-inflammatory
          1. By Value
        5. Anti-glaucoma
          1. By Value
        6. Others
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Dry Eye
          1. By Value
        3. Allergies
          1. By Value
        4. Glaucoma
          1. By Value
        5. Infection
          1. By Value
        6. Retinal Disorders
          1. By Value
        7. Uveitis
          1. By Value
        8. Others
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Topical
          1. By Value
        3. Local Ocular
          1. By Value
        4. Systemic
          1. By Value
      4. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Gels
          1. By Value
        3. Eye Solutions and Suspensions
          1. By Value
        4. Capsules and Tablets
          1. By Value
        5. Eye drops
          1. By Value
        6. Ointments
          1. By Value
      5. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-Allergy
        1. By Value
      3. Anti-VEGF agents
        1. By Value
      4. Anti-inflammatory
        1. By Value
      5. Anti-glaucoma
        1. By Value
      6. Others
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Dry Eye
        1. By Value
      3. Allergies
        1. By Value
      4. Glaucoma
        1. By Value
      5. Infection
        1. By Value
      6. Retinal Disorders
        1. By Value
      7. Uveitis
        1. By Value
      8. Others
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Topical
        1. By Value
      3. Local Ocular
        1. By Value
      4. Systemic
        1. By Value
    5. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Gels
        1. By Value
      3. Eye Solutions and Suspensions
        1. By Value
      4. Capsules and Tablets
        1. By Value
      5. Eye drops
        1. By Value
      6. Ointments
        1. By Value
    6. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    7. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-Allergy
          1. By Value
        3. Anti-VEGF agents
          1. By Value
        4. Anti-inflammatory
          1. By Value
        5. Anti-glaucoma
          1. By Value
        6. Others
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Dry Eye
          1. By Value
        3. Allergies
          1. By Value
        4. Glaucoma
          1. By Value
        5. Infection
          1. By Value
        6. Retinal Disorders
          1. By Value
        7. Uveitis
          1. By Value
        8. Others
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Topical
          1. By Value
        3. Local Ocular
          1. By Value
        4. Systemic
          1. By Value
      4. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Gels
          1. By Value
        3. Eye Solutions and Suspensions
          1. By Value
        4. Capsules and Tablets
          1. By Value
        5. Eye drops
          1. By Value
        6. Ointments
          1. By Value
      5. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Ophthalmic Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Alcon
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis Ag
    3. Johnson & Johnson ServicesInc.
    4. Bausch Health
    5. Merck & Co.Inc.
    6. Regeneron PharmaceuticalsInc.
    7. Coherus BiosciencesInc.
    8. Allergan
    9. Bayer Ag
    10. Pfizer Inc
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global ophthalmic perimeters market size was USD 270 million in 2021. It is estimated to reach an expected USD 400 million by 2030 at a CAGR of 4.5% during the forecast period (2022-2030). Factors such as expansion of nonprofit organizations and
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.